Collective Acquisition Corp. II - Warrants (CAIIW)

On our desk, we are monitoring CAIIW very closely because the warrants are hovering around $0.21 to $0.24 on practically zero daily volume. When you look at the Q2 2026 financials, the SPAC is holding roughly $255.6 million in trust with a cash floor per public share calculated at $10.10. However, the going concern disclosures in the 10-Q filing remind us that they are still a blank-check vehicle hunting for a target before the October 2027 outside date. Sentiment remains muted with no active redemption elections on file yet.

From a risk management standpoint, holding warrants like CAIIW requires keeping a strict eye on liquidity. With average volumes dropping significantly and daily trades occasionally logging in the single digits, scaling in or out of this position without moving the bid-ask spread is nearly impossible right now. The positive net income of $1.01 million for Q2 is purely a function of interest on trust investments offsetting modest GandA costs, not operational cash flow.

Watching the market chatter on TradingView and Stocktwits reveals a complete lack of retail engagement right now. There are zero active discussion threads or 'minds' posted for CAIIW, which tells me the instrument is completely off the active radar for short-term momentum traders. For a quantitative fund, this means low implied volatility pricing relative to the long-dated 2031 expiration, but the lack of an announced target makes sizing an uphill battle.

When analyzing the SPAC structure for Collective Acquisition Corp. II, I focus heavily on the capital setup: 25.3 million Class A shares redeemable at an initial trust amount of $10.05 and a recorded redemption value of $10.10, complemented by private placement warrants. Because no redemption election or business combination vote is currently on file, the warrants behave entirely as out-of-the-money options on the eventual success of management finding a merger partner before late 2027.

As a portfolio manager reviewing small-cap SPAC paper, CAIIW looks like a classic patient-capital play. With the outside date stretching out to October 2027, management has plenty of runway to source a deal, but carrying the going concern warning in their filings is par for the course. Until an LOI or definitive agreement drops, these warrants will likely remain pinned in the low-$0.20 range with minimal price discovery.